BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 12592122)

  • 1. Unsuspected skeletal sarcoidosis mimicking metastatic disease on FDG positron emission tomography and bone scintigraphy.
    Ludwig V; Fordice S; Lamar R; Martin WH; Delbeke D
    Clin Nucl Med; 2003 Mar; 28(3):176-9. PubMed ID: 12592122
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Osseous Sarcoidosis Mimicking Metastatic Cancer on Positron Emission Tomography.
    Ashamalla M; Koutroumpakis E; McCarthy L; Hegener P; Grimm R; Mehdi S
    J Oncol Pract; 2016 Jul; 12(7):697-8. PubMed ID: 27407163
    [No Abstract]   [Full Text] [Related]  

  • 3. Central skeletal sarcoidosis mimicking metastatic disease.
    Talmi D; Smith S; Mulligan ME
    Skeletal Radiol; 2008 Aug; 37(8):757-61. PubMed ID: 18401580
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Whole-body MR imaging for detection of bone metastases in children and young adults: comparison with skeletal scintigraphy and FDG PET.
    Daldrup-Link HE; Franzius C; Link TM; Laukamp D; Sciuk J; Jürgens H; Schober O; Rummeny EJ
    AJR Am J Roentgenol; 2001 Jul; 177(1):229-36. PubMed ID: 11418435
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A case of skeletal sarcoidosis imitating skeletal metastases on bone scintigraphy.
    Nijjar SS; Leslie WD
    CMAJ; 2008 Jan; 178(2):153-4. PubMed ID: 18195288
    [No Abstract]   [Full Text] [Related]  

  • 6. Prevalence and patterns of bone metastases detected with positron emission tomography using F-18 FDG.
    Nakamoto Y; Osman M; Wahl RL
    Clin Nucl Med; 2003 Apr; 28(4):302-7. PubMed ID: 12642709
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FDG positron emission tomography of bone involvement in sarcoidosis.
    Aberg C; Ponzo F; Raphael B; Amorosi E; Moran V; Kramer E
    AJR Am J Roentgenol; 2004 Apr; 182(4):975-7. PubMed ID: 15039174
    [No Abstract]   [Full Text] [Related]  

  • 8. F-18 FDG PET/CT can help differentiate SAPHO syndrome from suspected metastatic bone disease.
    Patel CN; Smith JT; Rankine JJ; Scarsbrook AF
    Clin Nucl Med; 2009 Apr; 34(4):254-7. PubMed ID: 19300064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone and bone marrow involvement in sarcoidosis.
    Yachoui R; Parker BJ; Nguyen TT
    Rheumatol Int; 2015 Nov; 35(11):1917-24. PubMed ID: 26248533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic usefulness of fluorine-18-alpha-methyltyrosine positron emission tomography in combination with 18F-fluorodeoxyglucose in sarcoidosis patients.
    Kaira K; Oriuchi N; Otani Y; Yanagitani N; Sunaga N; Hisada T; Ishizuka T; Endo K; Mori M
    Chest; 2007 Apr; 131(4):1019-27. PubMed ID: 17426205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 18F-fluorodeoxyglucose-positron emission tomography and bone scintigraphy for detecting bone metastases in patients with malignancies of the upper aerodigestive tract.
    Kim MR; Roh JL; Kim JS; Choi SH; Nam SY; Kim SY
    Oral Oncol; 2008 Feb; 44(2):148-52. PubMed ID: 17350879
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fluorodeoxyglucose positron emission tomography (FDG-PET) is useful in the diagnosis of neurosarcoidosis.
    Bolat S; Berding G; Dengler R; Stangel M; Trebst C
    J Neurol Sci; 2009 Dec; 287(1-2):257-9. PubMed ID: 19755199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical images: Bone sarcoidosis mimicking multiple metastases.
    Mosnier E; Siles P; Ebbo M; Bernit E; Veit V; Tintignac A; Chagnaud C; Harlé JR; Schleinitz N
    Arthritis Rheum; 2011 Jun; 63(6):1542. PubMed ID: 21630244
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparison and discrepancy of 18F-2-deoxyglucose positron emission tomography and Tc-99m MDP bone scan to detect bone metastases.
    Kao CH; Hsieh JF; Tsai SC; Ho YJ; Yen RF
    Anticancer Res; 2000; 20(3B):2189-92. PubMed ID: 10928175
    [TBL] [Abstract][Full Text] [Related]  

  • 15. F-18-fluorodeoxyglucose positron emission tomography-guided sampling of mediastinal lymph nodes in the diagnosis of cardiac sarcoidosis.
    Simonen P; Lehtonen J; Kandolin R; Schildt J; Marjasuo S; Miettinen H; Airaksinen J; Vihinen T; Tuohinen S; Haataja P; Kupari M
    Am J Cardiol; 2015 Nov; 116(10):1581-5. PubMed ID: 26411357
    [TBL] [Abstract][Full Text] [Related]  

  • 16. False-positive finding in FDG-PET in a patient with seminoma and sarcoidosis.
    Liepe K
    Acta Clin Belg; 2015 Apr; 70(2):138-40. PubMed ID: 25409626
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiac magnetic resonance imaging-indeterminate/negative cardiac sarcoidosis revealed by
    Sasson SC; Russo R; Chung T; Chu G; Hunyor I; Williamson J; Murad A; Kane A; Riminton S; Limaye S
    J Med Case Rep; 2017 Oct; 11(1):291. PubMed ID: 29052526
    [TBL] [Abstract][Full Text] [Related]  

  • 18. False-positive bone metastases on PET/CT secondary to sarcoidosis in a patient with rectal cancer.
    Montini KM; Tulchinsky M
    Clin Nucl Med; 2012 Mar; 37(3):307-10. PubMed ID: 22310266
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparing whole body 18F-2-deoxyglucose positron emission tomography and technetium-99m methylene diophosphate bone scan to detect bone metastases in patients with non-small cell lung cancer.
    Hsia TC; Shen YY; Yen RF; Kao CH; Changlai SP
    Neoplasma; 2002; 49(4):267-71. PubMed ID: 12382027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Results of 188 whole-body fluorodeoxyglucose positron emission tomography scans in 137 patients with sarcoidosis.
    Teirstein AS; Machac J; Almeida O; Lu P; Padilla ML; Iannuzzi MC
    Chest; 2007 Dec; 132(6):1949-53. PubMed ID: 17925421
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.